Wender P H, Reimherr F W
Department of Psychiatry, University of Utah School of Medicine, Salt Lake City 84182.
Am J Psychiatry. 1990 Aug;147(8):1018-20. doi: 10.1176/ajp.147.8.1018.
The authors treated 19 adults with attention-deficit hyperactivity disorder with an open trial of bupropion. These patients had received maintenance stimulant medication or monoamine oxidase inhibitors for an average of 3.7 years. Fourteen of the patients experienced moderate to marked benefit from bupropion; ten of these patients chose to continue bupropion rather than their former medication. These results suggest that bupropion may be an alternative to stimulants in treating some adults with attention-deficit hyperactivity disorder.
作者对19名患有注意力缺陷多动障碍的成年人进行了安非他酮的开放试验。这些患者平均接受维持性兴奋剂药物或单胺氧化酶抑制剂治疗3.7年。14名患者从安非他酮中获得了中度至显著的疗效；其中10名患者选择继续使用安非他酮而非之前的药物。这些结果表明，在治疗一些患有注意力缺陷多动障碍的成年人时，安非他酮可能是兴奋剂的一种替代药物。
